Secondary |
Hypertension |
13.7% |
Hiv Infection |
11.8% |
Hyperlipidaemia |
9.8% |
Blood Cholesterol Increased |
8.8% |
Depression |
8.8% |
Prophylaxis |
6.9% |
Type 2 Diabetes Mellitus |
6.9% |
Onychomycosis |
5.9% |
Dyslipidaemia |
4.9% |
Hypersensitivity |
3.9% |
Ulcer |
3.9% |
Blood Pressure Abnormal |
2.9% |
Blood Triglycerides Increased |
2.0% |
Drug Use For Unknown Indication |
2.0% |
Hepatitis B |
2.0% |
Osteoarthritis |
2.0% |
Arrhythmia |
1.0% |
Blood Triglycerides Abnormal |
1.0% |
Blood Uric Acid Abnormal |
1.0% |
Dysuria |
1.0% |
|
Eye Swelling |
16.0% |
Pancreatitis Necrotising |
16.0% |
Myalgia |
8.0% |
Tachypnoea |
8.0% |
Blood Cholesterol Increased |
4.0% |
Dengue Fever |
4.0% |
Disorientation |
4.0% |
Dysentery |
4.0% |
Hepatic Failure |
4.0% |
Hyperkalaemia |
4.0% |
Pancreatitis Acute |
4.0% |
Prothrombin Time Prolonged |
4.0% |
Swelling Face |
4.0% |
Toxic Epidermal Necrolysis |
4.0% |
Toxicity To Various Agents |
4.0% |
Vomiting |
4.0% |
Weight Increased |
4.0% |
|
Concomitant |
Hypertension |
20.2% |
Product Used For Unknown Indication |
14.8% |
Diabetes Mellitus |
10.2% |
Hiv Infection |
6.6% |
Type 2 Diabetes Mellitus |
6.6% |
Drug Use For Unknown Indication |
6.0% |
Rheumatoid Arthritis |
4.8% |
Blood Cholesterol Increased |
3.2% |
Depression |
2.9% |
Neoplasm Malignant |
2.9% |
Blood Cholesterol |
2.8% |
Hypercholesterolaemia |
2.8% |
Unevaluable Event |
2.6% |
Dyslipidaemia |
2.2% |
Cardiac Disorder |
2.0% |
Prostate Cancer |
2.0% |
Blood Triglycerides Increased |
1.9% |
Osteoporosis |
1.9% |
Prophylaxis |
1.9% |
Chronic Lymphocytic Leukaemia |
1.7% |
|
Weight Decreased |
11.3% |
Weight Increased |
10.0% |
Sepsis |
7.5% |
Anal Abscess |
6.3% |
Death |
5.0% |
Hypertension |
5.0% |
Septic Shock |
5.0% |
Vomiting |
5.0% |
Wheezing |
5.0% |
Wound |
5.0% |
Dyspnoea |
3.8% |
Heart Rate Decreased |
3.8% |
Nausea |
3.8% |
Off Label Use |
3.8% |
Pelvic Fracture |
3.8% |
Pseudomyxoma Peritonei |
3.8% |
Tendon Rupture |
3.8% |
Urticaria |
3.8% |
Blood Glucose Increased |
2.5% |
Cardiac Arrest |
2.5% |
|
Interacting |
Pain In Extremity |
38.9% |
Hyperlipidaemia |
22.2% |
Hypercholesterolaemia |
16.7% |
Tendon Pain |
11.1% |
Type Iii Hyperlipidaemia |
11.1% |
|
|